Vivos Therapeutics (VVOS) EBT Margin (QoQ) (2020 - 2026)
Vivos Therapeutics (VVOS) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.93 Mn | 3.13 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,108.00 |
| Dec 31, 2025 | -10,224.00 |
| Sep 30, 2025 | 5,162.00 |
| Jun 30, 2025 | -311.00 |
| Mar 31, 2025 | -5,010.00 |
| Dec 31, 2024 | -1,024.00 |
| Sep 30, 2024 | -2,016.00 |
| Jun 30, 2024 | 6,245.00 |
| Mar 31, 2024 | -39,845.00 |
| Dec 31, 2023 | 35,180.00 |
| Sep 30, 2023 | 9,942.00 |
| Jun 30, 2023 | -11,867.00 |
| Mar 31, 2023 | 11,253.00 |
| Dec 31, 2022 | -2,870.00 |
| Sep 30, 2022 | 3,913.00 |
| Jun 30, 2022 | -2,082.00 |
| Mar 31, 2022 | 2,239.00 |
| Dec 31, 2021 | -4,873.00 |
| Sep 30, 2021 | -3,005.00 |
| Jun 30, 2021 | 867.00 |